Nanobiotechnology research has recently provided numerous basic and applied advances
in the health sector. Nanocarriers have been developed for efficient drug delivery and …

Polymeric nanocarriers (PNs) have demonstrated to be a promising alternative to treat
intracellular infections. They have outstanding performance in delivering antimicrobials …

Despite the fact that nanocarriers as drug delivery systems overcome the limitation of
chemotherapy, the leakage of encapsulated drugs during the delivery process to the target …

Neurodegenerative diseases (NDs), such as Parkinson's Disease (PD), Alzheimer's Disease
(AD), Multiple Sclerosis (MS) and amyotrophic lateral sclerosis (ALS), are characterized by …

Tuberculosis (TB) is currently the second deadliest infectious disease. Existing
antitubercular therapies are long, complex, and have severe side effects that result in low …

Pathogenic bacterial infections represent an ever-growing crisis, now significantly
threatening life expectancy across the worldwide population and thus novel approaches to …

The inappropriate and inconsistent use of antibiotics in combating multidrug-resistant
bacteria exacerbates their drug resistance through a few distinct pathways. Firstly, these …

Tuberculosis (TB) is a global epidemic that kills over a million people every year, particularly
in low-resource communities. Mycobacterium tuberculosis, the most common bacterium that …

The long-term treatment of tuberculosis (TB) sometimes leads to nonadherence to treatment,
resulting in multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis …

A person infected with drug-resistant tuberculosis (DR-TB) is the one who does not respond
to typical TB treatment. DR-TB necessitates a longer treatment period and a more difficult …